A lysosomal pathway, characterized by partial rupture of lysosomal membranes and cathepsin B activation, is activated during camptothecin (CPT)-induced apoptosis in U937 and Namalwa cancer cells. These lysosomal events occur simultaneously with mitochondrial permeabilization and caspase activation. In U937 cells, blocking mitochondrial permeability transition pore with cyclosporin A and bongkrekic acid reduces mitochondrial and lysosomal rupture, suggesting that lysosomal rupture may be dependent, in part, on mitochondrial disruption. Overexpressing bcl-xL, an antiapoptotic protein known to preserve mitochondrial functions, also impedes lysosomal and mitochondrial disruption in both cell lines, indicating signaling between the two organelles. In addition, no evidence was obtained of bcl-2-like proteins targeting lysosomes. Caspase activities, including caspase-2L, are required for lysosomal and mitochondrial disruption, and lysosomal cathepsin B slightly participates in apoptosis propagation after CPT, although not essential for apoptosis activation. Our study provides evidence for the participation of a lysosomal pathway during DNA damage-induced cell death. Our data suggest that caspase activation and mitochondrial disruption represent cellcontext-specific mechanisms by which DNA damage leads to lysosomal rupture, and that lysosomal cathepsins could slightly participate in apoptosis propagation after CPT.
Introduction
In the past decade, great efforts have been made to better understand and elucidate the complex molecular pathways leading to apoptosis. As a site of convergence for multiple deathinducing stimuli, the mitochondria is a finely regulated decision center that controls life and death by releasing apoptogenic factors, such as cytochrome c, in cytosol. 1 Recently, a new pathway involving lysosomes has emerged. The lysosomal pathway of apoptosis involves moderate rupture of lysosomes, often referred to as small-scale lysosomal leakage (ssLL), and subsequent release of lysosomal cathepsins into the cytosol. [2] [3] [4] Lysosomal rupture and cathepsin activation have been linked to apoptosis after various insults, including oxidative stress, 5 lysosomotropic photosensitizer agents, 6, 7 serum withdrawal, 5 Fas and tumor necrosis factor-a ligation, 5, 8 increased sphingosine 9 and endogenous ceramide levels, 10 DNA damage, 11 and microtubule-stabilizing agents. 12 While some models of apoptosis appear to be dependent on the cathepsins and do not need caspase activation, 13 others involve both cathepsins and caspases. 8, 11, 14 Direct activation of caspases by cathepsins is unlikely because the apoptotic caspases are rather poor substrates for most cathepsins; 3 hence, the possible existence of intermediary molecules. Good candidates are the lysoapoptases, a new class of proteases that are activated by cathepsins within the lysosomal compartment, then translocated to the cytosol where they can process and activate procaspase-3. 14 Another aspirant is the bcl-2 family member Bid, which is apparently cleaved by lysosomal proteases producing a truncated Bid (tBid) fragment which may translocate to the mitochondria and induce cytochrome c release, thus connecting lysosomal rupture to the mitochondrial pathway of apoptosis. 3 Though lysosomal rupture and cytosolic translocation/activation of the cathepsins occurred before cytochrome c release in several studies, there is still some uncertainty and surely much to elucidate concerning the molecular connections between the lysosomal and mitochondrial apoptotic pathways. In this study, we investigated the molecular connections between the lysosomal and well-described mitochondrial apoptotic pathways after DNA damage induced by camptothecin (CPT), a DNA topoisomerase I inhibitor.
Materials and methods

Cell lines and drug treatment
The human B lymphoma Namalwa and the human monocytelike U937 cell lines were obtained from the American Type Culture Collection (Manassas, VA, USA). The procurement of stable Namalwa and U937 cells expressing HA-Bcl-xL has been described previously. 15, 16 To obtain the episomal pCep4-U6-si(hp)RNA expression vector, first the episomal pCep4 vector (Invitrogen, San Diego, CA, USA) was digested at SalI to remove sequences of the CMV promoter, multiple cloning site, and SV40 polyadenylation signal. The U6 promoter and BamH1/ HindIII cloning site sequences of pSilencer 2.0-U6 vector (Ambion, Austin, TX, USA) were amplified by PCR using specific adapter primers containing SalI sequences. The amplified fragment was first cloned in pCR2.1-Topo vector (TA cloning system; Invitrogen), sequenced, and then subcloned at the SalI restriction sites of the modified pCep4 vector. Then, caspase-2 hairpin si(hp)RNA-encoding oligonucleotides (sense, GATCCCACAGCTGTT GTTGAGCGAATTCAAGAGATTCGCT CAACAACAGCTGTTTTTTTGGAAA; antisense, AGCTTTTC CAAAAAAACAGCTGTTGTTGAGCGAATCTCTTGAATTCGCT CAACAACAGCTGTGG) were annealed and ligated into BamH1/HindIII restriction sites of pCep4-U6-si(hp)RNA. Purified pCep4-U6-si(hp)-caspase-2 construct was transfected in Namalwa cells by electroporation at 0.27 kV. Transfected cells were grown under hygromycin B1 selection at 250 mg/ml, and 1.0 mg/ml for 2-3 months to obtain stable lines before performing the experiments. All cells were treated with CPT at a concentration of 1.0 mM for 30 min, and then grown in drug-free medium. When indicated, the cells were pretreated with one of the following inhibitors: 50 mg/ml CsA, 50 mM BkA, 100 mM Z-VAD-FMK, 10 mM Z-FA-DMK for 1 h before CPT treatment, maintained during CPT treatment, and added to culture media after CPT treatment.
Assessment of kDCm and ssDLL kDCm was assessed by JC-1 staining. 17 At the indicated times (h) after CPT treatment, 1 Â 10 6 cells were incubated with 10 mg/ ml JC-1 in complete culture medium for 15 min at room temperature, washed twice, and resuspended in 500 ml of PBS and submitted to flow cytometry analysis. For the assessment of ssDLL, two methods were used and compared. First, at various times after drug treatment, 1 Â 10 6 cells were incubated with 1 mM AO in complete culture medium for 15 min at 371C and, then, cells were washed twice and resuspended in 500 ml of fresh culture medium before analysis by flow cytometry (uptake method). 5, 18 In the second assay, cells were loaded with 1 mM AO in complete culture medium for 15 min at 371C prior to drug treatment. At various times after drug treatment, 1 Â 10 6 cells were washed twice and resuspended in 500 ml of fresh culture medium before analysis by flow cytometry (relocation method). 18, 19 Loss of JC-1 orange fluorescence was measured with the FL2 channel, loss of lysosomial AO red fluorescence with the FL3 channel, and increase in cytosolic AO green fluorescence with the FL1 channel of a Coulter EPICS XL-MLC flow cytometer. At least 10 000 cells per sample were acquired in histograms, and the results are expressed as the percentage of total cells presenting kDCm or ssDLL.
Oxidative stress detection
Superoxide anion production served as a parameter of cellular oxidative stress. Cells were incubated with 5 mM DHE for 1 h at 371C, then treated with CPT or 100 mM DMNQ, as a positive control. At the indicated times (h) after treatment, 1 Â 10 6 cells were washed twice, resuspended in 500 ml PBS, then analyzed by flow cytometry with recording on the FL2 channel of the Coulter EPICS XL-MLC flow cytometer.
Analysis of DNA fragmentation
The kinetics of DNA fragmentation were monitored and quantitated by DNA filter elution assays and results are expressed as percentage of DNA fragmentation as described. 20 DNA content was also measured by flow cytometry after PI staining with recording on the FL2 channel of the Coulter EPICS XL-MLC flow cytometer. The results are expressed as the percentage of cells presenting hypoploid DNA content (sub-G1 peak).
Enzymatic assays
For the measurement of enzyme activities, cellular extracts were prepared in lysis buffer containing 100 mM Hepes (pH 7.5), 5 mM EDTA, 5 mM DTT, 20% (v/v) glycerol, and 0.3% (v/v) Igepal. Protein aliquots (100 mg) were incubated with 200 mM of the caspase-3-like substrate Ac-DEVD-AMC or with 20 mM of the cathepsin B substrate Z-RR-AMC, in reaction assay mixtures (500 ml) containing 100 mM HEPES (pH 7.5), 100 mM NaCl, 10% glycerol, 0.1% (w/v) CHAPS, 10 mM DTT, and 1 mM EDTA for caspase-3-like activity, and 0.4 mM sodium acetate buffer (pH 5.5) and 4 mM EDTA for cathepsin B activity. Enzymatic activities were determined as initial velocities at 371C in a dual luminescence fluorometer at an excitation wavelength of 380 nm and an emission wavelength of 460 nm, and expressed as relative intensity/min/mg.
Results and discussion
Lysosomes are disrupted after CPT treatment in U937 and Namalwa cells
Human monocytic-like leukemia U937 and B lymphoma Namalwa cells, two p53-defective cell lines, are highly sensitive to DNA damage and rapidly die by apoptosis after short treatment with the DNA-damaging drug CPT, a DNA topoisomerase I inhibitor. The apoptotic death of these cells is associated with quick involvement of a mitochondrial pathway, within 2-3 h after drug treatment, that is linked with rapid translocation to mitochondria of multiple proapoptotic proteins of the bcl-2 family, cytochrome c release, Apaf-1 oligomerization, caspase activation, DNA fragmentation, and typical morphological changes of cell death. 15, 16, 21, 22 Loss of mitochondrial inner transmembrane potential (kDCm), activation of caspase-3-like enzymes, DNA fragmentation, and sub-G1 cell populations rapidly appear in CPT-treated U937 ( Figure 1a ) and Namalwa cells (Figure 1b) . The magnitude of caspase activation and DNA fragmentation, and the appearance of sub-G1 cells are similar between both cell types, while the percentage of cells undergoing kDCm is greater in U937 cells, about 40% after 4 h, compared to a peak value of approximately 20% for Namalwa cells (Figure 1a and b) , reflecting the fact that mitochondrial outer membrane permeabilization leads to various levels of kDCm depending on the cellular context. 1 Both ssDLL, measured on the FL3 channel with the uptake (open square) and relocation methods (open circles), and cathepsin B activation also occur within 2-3 h after CPT treatment in these cell lines (Figure 1c and d) . Similar patterns, between the uptake and relocation methods, were observed when ssDLL were measured on the FL1 channel after CPT treatment (data not shown). Strikingly, the kinetics of ssDLL and cathepsin B activation occurred simultaneously to those of kDCm and caspase activation. As lysosomal disruption has been often observed in oxidative stress-induced apoptosis, we evaluated the possibility that oxidative stress was generated during CPTinduced cell death. Even 4-6 h after treatment, neither U937 (Figure 1e ) nor Namalwa (Figure 1f ) cells showed the presence of superoxide anions after CPT. Cells exposed to the quinone DMNQ served as positive controls. These results show that lysosomes undergo disruption associated with ssDLL and cathepsin B activation simultaneously with kDCm and caspase activation by CPT. These events are independent of oxidative stress after CPT treatment.
Blockade of the mitochondria permeability transition pores (mPTP) partially protects from CPT-mediated kDCm and ssDLL in U937 cells. Permeabilization of the outer mitochondrial membrane may be caused, in part, by the opening of mPTP or megachannels. The major constituents of mPTP are the voltagedependent anion channel-1 (VDAC1), the adenine nucleotide translocator (ANT), the peripheral benzodiazepine receptor, and the mitochondrial matrix enzyme cyclophilin D. As a result of mPTP opening, DCm could be dissipated, and apoptogenic factors, notably cytochrome c, are released in cytosol. 1 To investigate the hierarchy between lysosomal and mitochondrial disruption, mPTP inhibitors were used to impede mPTP opening. We incubated CPT-treated U937 and Namalwa cells with the mPTP inhibitors CsA and BkA. CsA inhibits the enzyme cyclophilin D which impedes ANT function, while BkA directly inhibits ANT. Obstructing mPTP with CsA (Figure 2a) or BkA (Figure 2b ) reduced both CPT-mediated kDCm and ssDLL in U937 cells. The protection conferred by CsA was significant during the first 6 h of CPT-induced death (Figure 2a) , while BkA significantly conferred protection over the first 4 h of CPT action (Figure 2b ). In contrast, the mitochondrial and lysosomal disruption observed after CPT treatment in Namalwa cells was not affected by blocking mPTP with CsA or BkA (data not shown). The similar reductions in the percentage of total cells undergoing kDCm and ssDLL after protection of the mitochondria with mPTP inhibitors in U937 cells suggests that lysosomal leakage depends, in part, on mitochondrial disruption in these cells. The observations that Namalwa cells incubated with CsA or BkA still undergo kDCm after CPT treatment indicate that, in these cells, dissipation of DCm may occur independently of ANT function. Indeed, BH3 peptides also evoked kDCm and apoptosis in an ANT-independent way, 23 and mPTP opening has recently been noted in the absence of ANT. 24 Perhaps, in Namalwa cells, kDCm could be a consequence of the alternative conductance mode for mPTP, 25 or of Bax oligomerization induced by CPT, 22 forming autonomous channels in the outer mitochondrial membrane or promoting dynamic alterations in the structure of the lipid bilayer. Bcl-xL prevents kDCm and ssLL after CPT treatment in U937 and Namalwa cells Overexpressing antiapoptotic bcl-2 protein has been shown to protect from lysosomal rupture in H 2 O 2 -treated cells, an effect associated with the prevention of oxidant-induced activation of phospholipase A2. 26 However, after DNA damage, the antiapoptotic effect of bcl-2 or bcl-xL had been associated with its protective action on the mitochondrial pathway of apoptosis. Thus, to further investigate the hierarchy between lysosomal and mitochondrial disruption, we used the previously reported Camptothecin-mediated small-scale lysosomal leakage C Paquet et al Namalwa and U937-transfected cell lines that overexpressed bcl-xL (Figure 2c ). In these cell lines, bcl-xL completely abolished for at least 48 h (Namalwa cells) or greatly reduced (U937 cells) caspase activation, DNA fragmentation, and apoptosis after various DNA-damaging treatments. 15, 16 Bcl-xL also significantly protected the mitochondria and lysosomes from CPT-mediated kDCm and ssDLL in U937 cells (Figure 2d) , and entirely in Namalwa cells (Figure 2e ). These results indicate Effect of mPTP and Bcl-xL on CPT-mediated kDCm and ssDLL. U937 cells were pretreated with (a) 50 mg/ml of CsA or (b) 50 mM of BkA, for 1 h before the addition of CPT, and the percentages of total cells with kDCm and ssDLL (on the FL3 channel with the uptake method) were measured by flow cytometry at the indicated times (h) after CPT treatment. Symbols represent the means7s.e. of at least three independent experiments. Camptothecin-mediated small-scale lysosomal leakage C Paquet et al that antiapoptotic bcl-xL protects against mitochondria and lysosome disruption after CPT, and could suggest again that lysosomal rupture depends, in part, on mitochondrial disruption. Although the possibility of bcl-xL directly preserving the integrity of the lysosomal membrane by itself cannot be discarded completely, lysosomal preservation as a consequence of the protective action of bcl-xL on the mitochondria is more likely. Indeed, it is well characterized that antiapoptotic bcl-xL promote cell survival by preventing mitochondrial dysfunction. 1 In fact, others have revealed that antiapoptotic bcl-2 overexpression was not sufficient to impede ssDLL induced by the lysosomotropic agent ciprofloxacin, which acts directly on lysosomes. 7 Also, in this study, we have investigated whether bcl-2 family members directly target lysosomes, or not. Even though it is apparently difficult to obtain highly purified organelle fractions, our results suggested that bcl-2 family proteins, at least the ones studied, did not target lysosomes during CPT-induced apoptosis (Supplementary material and Supplementary Figure 1 ).
kDCm and ssDLL are dependent on caspase activation in U937 and Namalwa cells
Apoptosis usually necessitates caspase activation that culminates in cell dismantling, DNA fragmentation, and cell death. Effect of caspase inhibition on CPT-mediated kDCm and ssDLL in U937 and Namalwa cells. U937 (a) and Namalwa (b) cells were pretreated with 100 mM Z-VAD-FMK for 1 h, then CPT was added for 30 min. At the indicated times (h) after CPT treatment, the percentages of total cells undergoing kDCm and ssDLL (on the FL3 channel with the uptake method) were measured by flow cytometry. (c) Silenced caspase-2L expression in Namalwa cells transfected with empty vector and pCep4-U6-siRNA-caspase-2 vector under hygromycin B1 selection at 250 mg/ml and 1.0 mg/ml (left panel). Membranes were also hybridized with anti-crkl monoclonal antibody as loading control and with anti-procaspase-9 and -3 antibodies. Control, empty vector-and Cep4-U6-siRNA-caspase-2 vector-transfected Namalwa cells (selected at 1.0 mg/ml hygromycin B1) were treated with CPT, and at the indicated times (h) after CPT treatment, DEVDase activities (c, right panel), and the percentages of total cells undergoing kDCm and ssDLL (on the FL3 channel with the uptake method) (d) were measured by flow cytometry. Symbols represent the means7s.e. of three independent experiments.
To investigate the role of caspase activation in CPT-mediated kDCm and ssDLL, U937 and Namalwa cells were treated with the pan-caspase inhibitor Z-VAD-FMK prior to CPT treatment. No caspase activities were measured in CPT-treated U937 and Namalwa cells incubated with Z-VAD-FMK (data not shown). Moreover, inhibition of caspase activities with Z-VAD-FMK completely abolished CPT-mediated kDCm and ssDLL in U937 (Figure 3a) and Namalwa (Figure 3b) cells. These results demonstrate that both kDCm and ssDLL require caspase activities after DNA damage. This is consistent with previous studies that show that caspase activities provoked kDCm, while caspase inhibitors impeded kDCm under certain circumstances. 27, 28 In addition, it had also been reported that active caspases could penetrate into mitochondrial intermembrane spaces following mPTP opening, leading to disruption of electron transport and resulting in kDCm. 29 Furthermore, evidence now supports a role for caspase-2L as an initiator protease activated prior to kDCm in DNA damage-induced apoptosis. 30 Thus, Namalwa cells expressing small hairpin interfering RNA were derived to silence caspase-2L expression and to investigate its role in CPT-mediated kDCm and ssDLL. These cells, transfected with Cep4-U6-si(hp)RNA-caspase-2 vector under hygromycin B1 selection (1.0 mg/ml), showed strong procaspase-2L expression inhibition, while not affecting procaspase-9 and -3 expression (Figure 3c, left panel) . Moreover, silencing caspase-2L expression delayed CPT-mediated DEVDase activities (Figure 3c , right panel) and both kDCm and ssDLL (Figure 3d ). These results demonstrate that caspase-2L acts upstream of both kDCm and ssDLL after DNA damage. However, our results do not permit discrimination between the following possibilities: whether the protection of lysosomes is a consequence of mitochondrial protection mediated by Z-VAD-FMK or by silencing caspase-2L expression, or whether specific caspases, including caspase-2L, play a direct role in lysosomal rupture, or both.
Lysosomal cathepsin B only slightly participates in CPTinduced cell death in U937 cells. Cathepsin B, one of the most abundant lysosomal proteases, has been involved in apoptosis. [2] [3] [4] We noted an increase of cathepsin B activity in CPT-treated U937 and Namalwa cells (Figure 1c and d) . To investigate the role of cathepsin B activation in CPT-induced apoptosis, cells were pretreated with the cathepsin B inhibitor Z-FA-DMK, and various CPT-mediated apoptotic events were monitored (Figure 4) . First, no cathepsin B activity was detected in CPT-treated U937 cells incubated with 10 mM Z-FA-DMK (Figure 4a ). Cathepsin B inhibition resulted in substantial reduction of caspase-3-like activities (Figure 4b ) and of the percentage of cells with kDCm (Figure 4c ), ssDLL (Figure 4d) , and sub-G 1
Figure 4
Effect of cathepsin B inhibition on parameters of CPT-induced apoptosis in U937 cells. U937 cells were pretreated with 10 mM Z-FA-DMK for 1 h, then CPT was added for 30 min. At the indicated times (h) after CPT treatment, (a) the kinetics of cathepsin B and (b) caspase-3-like activites were measured by spectrofluorometry. The percentages of total cells exhibiting (c) kDCm, (d) ssLL (on the FL3 channel with the uptake method), and (e) hypoploid sub-G 1 DNA content were analyzed by flow cytometry. Symbols represent the means7s.e. of at least three independent experiments. nSignificance with the paired Student's t-test: Po0.05. (f) Native Bid expression patterns in U937 and Namalwa cells were monitored from total cellular extracts at the indicated times (h) after CPT (1.0 mM; 30 min), VP16 (50 mM; continuous), and TNF-a/CHX (1.0 mg/ 2.0 mg/ml; continuous) treatment. Membranes were also hybridized with anti-b-actin monoclonal antibody as loading control.
DNA content (Figure 4e) , over the first 4 h in CPT-treated U937 cells. In contrast, inhibition of cathepsin B had no significant effect over the same events in CPT-treated Namalwa cells (data not shown). Therefore, these results suggest that cathepsin B activity contributes only substantially to caspase-3-like enzyme activation as well as to kDCm and ssDLL, but its activity does not appear essential for apoptosis to occur. Nevertheless, cathepsin B is only one of the many cathepsins that can be activated after ssDLL. Further investigation is needed to dissect the importance of other cathepsins, including cathepsin L and D, in the promotion or amplification of apoptosis after CPT treatment.
The BH3-only Bid protein can be cleaved by lysosomal proteases, including cathepsin B, that produces a truncated fragment with characteristics similar to tBid, the active fragment generated by caspase-8. 3 To investigate if Bid undergoes cleavage during CPT-induced cell death, and, thus, bridges a link between lysosomal proteases and the mitochondria, the kinetics of native Bid expression were monitored in U937 and Namalwa cells after CPT treatment. As positive controls, the cells were also treated with etoposide (VP16) and TNF-a in association with cyclohexamide (CHX). Native Bid expression was significantly reduced as early as 4-6 h after VP16, and by 24 h after TNF-a/CHX in U937 and Namalwa cells (Figure 4f ). In contrast, native Bid expression levels were not reduced after CPT treatment, within time-frames where kDCm and ssDLL occurred, suggesting that Bid did not undergo cleavage and did not bridge a link between lysosomes and mitochondria in these cells after CPT treatment.
Conclusion
Our study demonstrates that lysosomal rupture and cathepsin B activation are early events during p53-independent apoptosis induced by CPT, occurring simultaneously with mitochondrial disruption and caspase activation. Our findings suggest that caspase activation, including caspase-2L as the apical caspase involved in the process, and mitochondrial disruption could represent cell context-specific mechanisms by which DNA damage leads to lysosomal rupture. In turn, lysosomal disruption may contribute to amplify these events in apoptotic cells.
